Adenoviruses are very efficient for gene delivery both in vitro and in vivo. They are able to infect actively dividing, as well as quiescent cells, they are stable and can be prepared at very high titre. Moreover, using this vector, cellspecific delivery can be achieved either by modification of the tropism of the adenovirus 1 or by transcriptional targeting. 2 Adenoviruses have been used for selective transgene expression in cancer cells, 3, 4 cardiac, 5 skeletal 6 and smooth muscle cells 7 for gene therapy purposes, as well as ectopic expression of transgenes to study the role and function of a particular gene product. 8 Transcriptional targeting involves the use of tissue-specific promoters that will be active only in the target cells and several studies have described promoters that maintain their selectivity when the expression cassette is delivered by an adenoviral vector. [4] [5] [6] [7] [8] However, for some promoters, this selectivity of transgene expression is changed, modulated or lost in an adenoviral genome environment. 9, 10 This was found to be the case for the promoter element of the ERBB2 gene. 9 The ERBB2 gene is frequently upregulated or selectively activated in common tumours, including breast, pancreatic and gastro-intestinal tract carcinomas. [11] [12] [13] A 500 bp 5Ј proximal promoter element cloned upstream of a transgene has been shown to drive expression in those breast cancer cell lines which overexpress the ERBB2 oncogene.
14 This observation made it an excellent candidate for exploitation in genetic prodrug activation therapy (GPAT). 15 In this strategy, cancerselective promoters (ie promoters of genes activated or transcriptionally up-regulated in tumours) are used to restrict the expression of 'suicide' genes to cancer cells. This suicide gene will then metabolise an inactive prodrug into a toxic compound, leading to the selective death of the transcriptionally targeted cells. In this context, we have previously demonstrated that the 500 bp promoter element of the ERBB2 gene was capable of selectively driving the expression of the herpes simplex thymidine kinase gene (HSVtk) and subsequently sensitising ERBB2-expressing cells to the cytotoxic effects of ganciclovir when the expression cassette (ERBB2 promoter-herpes simplex thymidine kinase gene-polyadenylation signal, referred to as ETA) was delivered in a plasmid vector or in a retrovirus. 9 However, the selective killing of ERBB2-positive cells was lost when the ETA cassette was delivered by E1-or E3-deleted replicationdeficient adenoviruses. 9 Among the various hypotheses that have been formulated to explain this loss of selectivity, 9, 10 we considered, in this study, the presence of enhancer elements or a 'cryptic' transcription start within the adenoviral genome. In order to insulate the ETA cassette from these putative dominant transcriptional activators we have used sequences capable of blocking the process of transcription and chose a 250 bp fragment containing the bovine growth hormone transcription stop signal (designated as Ins in this report). The ETA cassette was flanked 5Ј and 3Ј by the Ins elements and the Ins-ETA insert was used to generate a recombinant E1-deleted type 5 adenovirus. The data presented in this report demonstrate that these Ins elements are capable of insulating the ETA cassette by restricting the selectivity of expression of the HSVtk gene to ERBB2-positive cells in the panel of five cell lines tested. 
Figure 2 Effect of Ad5-Ins-1ETAS upon the sensitivity of ERBB2-positive cell lines to ganciclovir. ERBB2-positive cells were infected at the indicated MOI with Ad5-Ins-1ETAS, trypsinised 24 h after infection and seeded at a density of 10 3 cells per well in a 96-well plate with various concentrations of ganciclovir (day 0). At day 5, the number of cells was estimated using a MTT assay (Promega). The results are presented as a percentage of cell survival of the ganciclovir-untreated cells and are the mean ± s.d. between quadruplicate samples.
The bovine growth hormone transcription stop signal used to insulate the ETA cassette is located on the plasmid pcDNA3 (bp 1000 to 1250; Invitrogen, Leek, The Netherlands) and was amplified by PCR using the primers: 5Ј CTA GCT AGC TAG ATA GTG TCA CCT AAA TGC TAG 3Ј (forward primer; the underlined sequence corresponds to a NheI site not present in the plasmid sequence) and 5Ј ATC CCC AGC ATG CCT GCT ATT 3Ј (reverse primer). The PCR reaction was performed in a volume of 50 l and the reaction mixture contained 200 m of each deoxynucleotide, 10 pmol of each primer, 50 ng of pcDNA3 template, 1.25 unit of Pfu DNA polymerase (Stratagene, Cambridge, UK) and 1 × PCR buffer (1.5 mm MgCl 2 , 25 mm KCl, 10 mm Tris-HCl, pH 8.8). The reaction mix was then heated for 3 min at 94°C, and subjected to 30 cycles of denaturation (9°C for 45 s), annealing (52°C for 45 s) and extension (72°C for 45 s). The PCR product (Ins element) was then cloned into pCRII (to generate pGV20) according to the manufacturer's instructions (Invitrogen) and sequenced to confirm its integrity. The Ins element was then transferred from the pCRII plasmid backbone to pBSK+ (XhoI/BamHI) to generate pGV22. The ETA cassette was then excised from pETA 9 by a BamHI digest and cloned into the BamHI site of pGV22. The semi-insulated Ins-ETA fragment was excised from pGV22 by a NotI digest, blunt-ended and cloned into the blunt-ended SpeI site of pGV20 to generate pGV26. The insulated transgene was then excised from pGV26 by digestion with NheI and cloned into the XbaI site of p⌬E1 sp1A (Microbix, Toronto, Canada). The recombinant adenovirus Ad5-Ins-1ETAS was then obtained according to the protocol of a commercially available kit (Microbix). The recombinant adenovirus Ad5-Ins-1ETAS was then cloned by two rounds of limiting dilution and purified by ultracentrifugation on a CsCl gradient and was shown to be replication-defective after infection of Hela cells (data not shown). Subsequent Southern blot analysis (not shown) showed that the recombinant Ad5-Ins-1ETAS only differs from the previously described 9 Ad5 1ETAS by the presence of the Ins elements flanking the ETA cassette ( Figure  1 ). Both Ad5-Ins-1ETAS and Ad5 1ETAS were prepared to a titre of 10 11 p.f.u./ml, as assessed by plaque formation after limiting dilution. For each virus preparation, the number of particles was also determined by optical absorbance at 260 nm after treatment of the viral particles with 0.1% SDS, as previously described. 16 The particle to infectivity ratios of the two different viral preparations were found to be very similar (40 for Ad5 1ETAS and 60 for Ad5-Ins-1ETAS), corresponding to biologically infective fractions of 2.5% and 1.7% for Ad5 1ETAS and Ad5-Ins-1ETAS, respectively.
In the experiments presented in Figure 2 , the ERBB2-expressing cell lines SK-BR-3 (breast carcinoma) and HPAF (pancreatic carcinoma) were infected with Ad5-Ins-1ETAS at the indicated multiplicity of infection (MOI), trypsinised 24 h after infection and seeded at a density of 10 3 cells per well in a 96-well plate with various concentrations of ganciclovir (day 0). At day 5, the number of viable cells was estimated using an MTT assay (Promega, Southampton, UK). As previously described for Ad5 1ETAS (recombinant adenovirus carrying a non- 
Figure 4 RT-PCR analysis of the Ad5 1ETAS-infected and Ad5-Ins-1ETAS-infected cells. ERBB2-positive (HPAF) and ERBB2-negative (T3M4) cell lines were not infected or infected with either Ad5 1ETAS or Ad5-Ins-1ETAS (MOI 10). Forty-eight hours later, total mRNAs were prepared using a RNeasy kit (Qiagen, Crawley, UK). The total RNAs were reverse-transcribed using the First Strand cDNA Synthesis kit (Pharmacia, St Albans, UK), according to the manufacturer's instructions (12 g of total RNA and 0.2 g of a random hexanucleotide as primer were used). The cDNAs obtained were then subjected to PCR amplification with either HSVtk-specific primers (5Ј AACAATGGGCATGCCTTATGC; 5Ј-TTATACAGGTCGCCGTTGGGG 3Ј with an expected PCR product of 540 bp) or GAPDH-specific primers (5Ј TGCCGTCTAGAAAAACCTGC 3Ј; 5Ј ACCCTGTTGCTGTAGCCAAA 3Ј with an expected PCR product of 233 bp). The PCR reactions were performed in a volume

to detect GAPDH expression). The reaction mixes were then heated for 3 min at 94°C, and subjected to 30 cycles of denaturation (94°C for 45 s), annealing (52°C for 40 s) and extension (72°C for 45 s), followed by 10 min of extension (72°C). The PCR products were then separated on a 2% agarose gel.
Figure 5 Effect of over-infection of ERBB2-negative cells with Ad5-Ins-1ETAS on the cell kill induced by 10 g/ml of ganciclovir. ERBB2-negative cells were infected with Ad5-Ins-1ETAS at various MOI or Ad5 1ETAS (MOI 10), trypsinised 24 h after infection and seeded at a density of 10 3 cells per well in a 96-well plate with various concentrations of ganciclovir (day 0). At day 5, the number of cells was estimated using an MTT assay (Promega). The results are presented as a percentage of cell survival of the ganciclovir-untreated cells and are the mean ± s.d. between quadruplicate samples.
insulated ETA cassette in the E1 region and previously described), 9 Ad5-Ins-1ETAS was capable of sensitising both ERBB2-expressing cell lines to the action of ganciclovir (Figure 2 ). The degree of sensitisation was comparable to that elicited by Ad5 1ETAS. 9 This observation demonstrates that these insulating elements do not affect the level of expression of the transgene in ERBB2-expressing cells. As expected, 9 the infection of a panel of ERBB2-negative cells (HBL 100, SV40 T antigen transformed normal breast epithelium; MDA-MB-231, breast carcinoma; and T3M4, pancreatic carcinoma) with Ad5 1ETAS at a MOI of 10 led to more than 75% of cell death, even at concentrations of ganciclovir as low as 1 g/ml ( Figure  3) . By contrast, infection of these cells with 100 MOI of Ad5-Ins-1ETAS caused no sensitisation to the prodrug (Figure 3) . Taken together, the data presented in Figures  2 and 3 demonstrate that the Ins elements are able to insulate the transgene and to restore the selectivity of expression conferred by the 500 bp ERBB2 promoter.
To confirm these conclusions, RT-PCR analysis was performed after infection of ERBB2-positive (HPAF) and ERBB2-negative (T3M4) cell lines (MOI of 10) with either Ad5 1ETAS or Ad5-Ins-1ETAS (Figure 4) . Forty-eight hours after infection, cDNAs were prepared and were subjected to PCR amplification, using HSVtk-specific or GAPDH-specific primers. Figure 4 shows that HSVtk expression can be detected when HPAF or T3M4 cells are infected with Ad5 1ETAS, reflecting the loss of selectivity of expression of the non-insulated ETA cassette. By contrast, HSVtk expression was only clearly detected in Ad5-Ins-1ETAS-infected HPAF cells (Figure 4 ), while only a very faint band was observed in Ad5-Ins-1ETAS-infected T3M4 cells after 30 cycles of amplification, reflecting a very low level of HSVtk expression. As a control, equivalent signals were obtained when these samples were subjected to amplification with GAPDH primers. Taken together, these data largely confirm that the Ins elements are able to insulate the ETA transgene. To test the degree of insulation provided by the Ins elements, the three ERBB2-negative cell lines were infected with Ad5-Ins-1ETAS, at MOI varying from 50 to 5000 or Ad5 1ETA at an MOI of 10 and subsequently exposed to 10 g/ml of ganciclovir for 5 days. Figure 5 clearly shows that infection with Ad5-Ins-1ETAS has no significant effect on the HBL 100 and MDA-MB-231 cell lines, even at a titre as high as MOI of 5000, while in the same experiment, only 20% of cells survived after infection with Ad5 1ETAS at an MOI of 10. In the T3M4 cell line, only infection with Ad5-Ins-1ETAS at an MOI of 5000 led to significant toxicity (66% cell survival at 5 days), while only 9% of cells survived after infection with the uninsulated virus Ad5 1ETAS at an MOI of 10 ( Figure 5) .
In this report, we have demonstrated the ability to restore the selectivity of expression of a transgene in an adenovirus environment by flanking the transgene in 5Ј and 3Ј with bovine growth hormone transcriptional stop sequences (Figures 2, 3 and 4) . This protects cells which do not express the ERBB2 oncogene from non-specific toxicity. Only at a dose of Ad5-Ins-1ETAS 500 times higher than the concentration necessary and sufficient to obtain the maximal effect in ERBB2-expressing cancer cells was there any sensitivity to ganciclovir for the ERBB2-negative cell line T3M4 (Figure 2 and data not shown).
To our knowledge, this is the first time that restoration of the selectivity of expression of a transgene in an adenoviral vector has been achieved. The insulating effect of the bovine growth hormone transcriptional stop sequences gives an insight into the mechanism by which the selectivity of expression is lost in the recombinant Ad5 ETA series: 9 DNA elements located within the adenoviral genome are likely to act in cis and dominantly affect transcription rather than an adenoviral protein acting in trans to alter the activity of the ERBB2 promoter.
Other insulating sequences have been suggested for protection of transgene expression. For example, matrix attachment regions (MARs) have been shown to insulate expression of genes in transferred genomic DNA fragments. 17 However, MARs are only efficient when the transgene is integrated into the genome of recipient cells and ineffective when positioned in an episomal element 17, 18 (ie in transient transfection experiments). The inefficiency of MARs as insulators was further demonstrated when particular MAR elements (a 3-kb fragment of the chicken lysozyme gene and a 2.6 kb of the human ␤-globin gene locus control region) incorporated into a herpes simplex virus type 1 vector failed to induce a sustained expression of the transgene. 19 As the adenovirus genome, like the herpes simplex virus type 1 genome, is maintained as episomal element in recipient cells, MARs may not be able to insulate the expression cassettes in adenoviral vectors. As an alternative, DNA sequences like, for example, the chicken ␤-globin insulator 20 may conserve their insulating properties in an adenoviral environment. However, no experimental evidence is currently available and further work is still needed to assess this approach.
In conclusion, the bovine growth hormone transcriptional stop sequences used in this study were able to restore the selectivity of expression driven by the ERBB2 promoter and may have application in other situations where a tissue-specific promoter is affected by elements present in the adenoviral genome. 10 
